FilingReader Intelligence
Zhongsheng Pharma cancels 1.6m shares after performance targets missed
July 30, 2025 at 05:41 PM UTC•By FilingReader AI
Guangdong Zhongsheng Pharmaceutical repurchased and cancelled 1.6 million restricted shares at 4.78 yuan each, totaling 7.8 million yuan.
The buyback occurred after the company's 2024 performance failed to meet conditions for its 2022 incentive plan, reducing total share capital to 849.9 million shares.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002317•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Guangdong Zhongsheng Pharmaceutical publishes news
Free account required • Unsubscribe anytime